Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Emergency contraception OTC

Executive Summary

Women's Capital Corporation's application to switch its Plan B emergency contraceptive from Rx to OTC status is expected to be considered by FDA's Nonprescription Drugs and Reproductive Health Drugs Advisory Committees in mid-December. Both committees are tentatively scheduled to meet Dec. 16. A switch application for Plan B was filed April 21...

You may also be interested in...



Barr’s women’s health strategy goes to Plan B

Barr acquires Women's Capital Corporation's emergency oral contraceptive Plan B. The company will continue to pursue over-the-counter status for Plan B; the emergency contraceptive is expected to be considered by FDA's Nonprescription Drugs & Reproductive Health Drugs Advisory Committees in mid-December (1"The Pink Sheet" Sept. 29, 2003, In Brief). Barr will also acquire "certain other assets and liabilities" from WCC...

US High Court Punts On ‘Objective Falsity’ FCA Standard

Can a false-claims suit be filed if doctors have different opinions about whether a treatment was necessary? The Supreme Court won’t say.

Warning Letter Close-Outs – February 2021

No device-related close-out letters were released by the US FDA last month.

UsernamePublicRestriction

Register

OM004078

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel